[The practical aspects of lipid management in secondary prevention].
Secondary prevention of ischaemic heart disease includes the important aim of reducing plasma lipids, as have been suggested by several recent trials focusing both on plaque regression-stabilization and on mortality (4S). The degree of acceptance of recommendations of the different panels of experts, however, has been low. Implementation of these secondary prevention measures in clinical practice requires the understanding of their pathophysiologic and epidemiologic basis, as well as an appropriate spread of experts recommendations and a good relationship of the different levels of health care to cardiac patients.